CSX-1004

Cessation Therapeutics, Inc. · Phase 1 active Biologic

At a glance

Generic name	CSX-1004
Sponsor	Cessation Therapeutics, Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CSX-1004 CI brief — competitive landscape report
CSX-1004 updates RSS · CI watch RSS
Cessation Therapeutics, Inc. portfolio CI